🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Congenital malformations result from an embryonic or foetal developmental d...
Status
Recruiting
Location
CHU clermont-Ferrand
Start Date
2025-11-18
Trial ID
NCT07370792
Treatments Being Tested
Poly(ADP-ribose) polymerase (PARP) inhibitors are anti-cancer treatments th...
Status
Recruiting
Location
Centre Hospitalier Universitaire d'Amiens Picardie Site Sud
Start Date
2024-09-24
Trial ID
NCT06572735
Treatments Being Tested
Nephrotic syndrome (NS) is a clinical picture common to several diseases re...
Status
Unknown
Location
Meyer Children's Hospital IRCCS
Start Date
2022-01-26
Trial ID
NCT06325098
Treatments Being Tested
RATIONALE: Imatinib mesylate may stop the growth of cancer cells by blockin...
Status
Completed
Location
Roswell Park Cancer Institute
Start Date
2008-10
Trial ID
NCT00509093
Background: Brain and spinal cord tumors are uncommon. But they contribute...
Status
Completed
Location
National Institutes of Health Clinical Center
Start Date
2016-09-01
Trial ID
NCT02851706
Treatments Being Tested
RATIONALE: Erlotinib may stop the growth of tumor cells by blocking some of...
Status
Completed
Location
University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center
Start Date
2007-11-19
Trial ID
NCT00720304
Treatments Being Tested
The purpose of this study is to identify novel biomarkers of kidney injury ...
Status
Completed
Location
University of Chicago
Start Date
2009-09-22
Trial ID
NCT00984035
Treatments Being Tested
The purpose of this study is to learn how people with BRCA1/2 mutations res...
Status
Recruiting
Location
Memorial Sloan Kettering Cancer Center
Start Date
2025-09-25
Trial ID
NCT07197723
Treatments Being Tested
A case-control study to identify microbiome and genetic differences between...
Status
Terminated
Location
Siberian State Medical University
Start Date
2020-09-01
Trial ID
NCT04119596
Treatments Being Tested
Age-Related Macular Degeneration (ARMD) is the most common cause of blindne...
Status
Completed
Location
CHU Brugmann
Start Date
2013-08-01
Trial ID
NCT02762188
Treatments Being Tested